Filter
1864
Filtered Results: 1864
Text search:
vaccine
doses
Featured
Recommendations
194
New Publications
481
Language
Document type
No document type
836
Studies & Reports
323
Guidelines
314
Strategic & Response Plan
107
Manuals
91
Fact sheets
89
Situation Updates
44
Training Material
28
Infographics
13
Resource Platforms
11
Brochures
4
Videos
3
App
1
Countries / Regions
India
94
Global
83
Congo, Democratic Republic of
51
South Africa
44
Kenya
43
Latin America and the Carribbean
36
Africa
35
Brazil
35
Nigeria
33
Senegal
33
Ethiopia
33
Uganda
31
Haiti
27
Tanzania
25
Nepal
24
Ghana
23
Sierra Leone
23
Bangladesh
23
Zambia
23
Malawi
20
Philippines
20
Western and Central Europe
20
Liberia
20
Rwanda
19
Cameroon
19
Zimbabwe
17
West and Central Africa
17
East and Southern Africa
17
Syria
16
Namibia
16
Benin
14
Ukraine
12
South Sudan
12
Burkina Faso
11
South–East Asia Region
11
Lesotho
10
Guinea
10
Mozambique
10
Middle East and North Africa
10
Pakistan
10
Venezuela
9
Cambodia
8
Mali
8
Myanmar / Burma
8
Niger
7
Eastern Europe
7
Yemen
7
Central African Republic
7
Angola
7
Indonesia
7
Colombia
6
Afghanistan
6
Lebanon
6
Madagascar
6
Guinea-Bissau
5
Germany
5
Eastern Europe and Central Asia
5
Côte d’Ivoire / Ivory Coast
5
Chad
5
Botswana
5
Togo
4
Chile
4
Argentina
4
Somalia
4
Peru
3
Asia
3
Western Pacific Region
3
Russia
3
Sudan
3
Eswatini/ Swaziland
3
El Salvador
2
Congo-Brazzaville
2
Burundi
2
Morocco
2
Saudi Arabia
2
Paraguay
2
France
2
Bolivia
2
Papua New Guinea
2
Sri Lanka
2
Palestine
2
Libya
2
Iraq
2
North Macedonia
1
Tajikistan
1
Gambia
1
Iran
1
Laos
1
Qatar
1
Bulgaria
1
Jordan
1
North America
1
Denmark
1
Tunisia
1
United Kingdom
1
Moldova
1
Djibouti
1
Egypt
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
812
Clinical Guidelines
236
Women & Child Health
124
Public Health
78
Key Resources
50
Capacity Building
16
Pharmacy & Technologies
14
Annual Report MEDBOX
1
Toolboxes
COVID-19
328
Rapid Response
97
AMR
80
HIV
64
TB
62
Malaria
55
Ebola & Marburg
51
NTDs
49
Polio
49
Cholera
48
Pharmacy
48
Caregiver
35
Conflict
31
Refugee
28
Planetary Health
24
Health Financing Toolbox
22
Mental Health
17
Global Health Education
17
NCDs
12
Natural Hazards
11
Zika
10
Specific Hazards
7
Disability
2
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their income level and allocation of domestic resources to medicine and vaccine procurement. Access to safe a...
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 newborns died annually from neonatal tetanus in the Americas. Neonatal tetanus is prevent...
Since May 2019, Confirmation of 4 new emergence of type 2 vaccine-derived poliovirus (VDPV2) in Bambari (2) and Bimbo (2) health districts without any genetic link between them and other known viruses ; Bambari Health District: CAF-RS4-BAM-19-058, onset of paralysis: May 02, 2019. 07 positive contac...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of multiple vaccine products with different charact...
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
A guide to increasing coverage and equity in all communities in the African Region
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat...
Update 2021; Immunization, Vaccines and Biologicals
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
To date, Samoa, Tonga, Fiji and American Samoa have reported measles cases. The outbreaks in Samoa and Tonga are caused by the D8 strain (genotype) of measles virus. Measles vaccine coverage varies in Pacific island countries and areas, ranging from 31% in Samoa to 99% in the Cook Islands, Nauru and...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo...
Many of the countries in the European Region receiving refugees from Ukraine are already offering vaccination services to children and adults. This is important to mitigate the risk of COVID-19 transmission among people travelling or living in close quarters, to protect the refugees from diseases th...
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health ...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
Responding to a polio outbreak. Guidelines
recommended
The occurrence of a case of wild polio in a previously polio free area as presently in Syria, whether through importation, laboratory accident, or mutation of vaccine virus (VDPV), should be considered a public health emergency, that requires a rapid and high quality response as utmost priority
